Equities research analysts expect that Teligent, Inc. (NASDAQ:TLGT) will post sales of $19.17 million for the current quarter, according to Zacks. Three analysts have issued estimates for Teligent’s earnings, with the highest sales estimate coming in at $19.90 million and the lowest estimate coming in at $18.70 million. Teligent reported sales of $16.15 million during the same quarter last year, which indicates a positive year over year growth rate of 18.7%. The firm is scheduled to announce its next quarterly earnings report on Thursday, October 26th.
According to Zacks, analysts expect that Teligent will report full-year sales of $19.17 million for the current financial year, with estimates ranging from $80.10 million to $80.90 million. For the next fiscal year, analysts expect that the firm will post sales of $118.31 million per share, with estimates ranging from $109.58 million to $136.60 million. Zacks Investment Research’s sales averages are an average based on a survey of research firms that that provide coverage for Teligent.
Teligent (NASDAQ:TLGT) last released its earnings results on Tuesday, August 8th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.04). Teligent had a positive return on equity of 1.49% and a negative net margin of 11.36%. The business had revenue of $18.40 million for the quarter, compared to the consensus estimate of $20.11 million. During the same quarter in the previous year, the company earned $0.02 earnings per share. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis.
Several brokerages recently issued reports on TLGT. Canaccord Genuity reiterated a “buy” rating and issued a $11.00 target price on shares of Teligent in a research report on Tuesday, August 8th. Roth Capital set a $9.00 target price on shares of Teligent and gave the stock a “buy” rating in a research report on Wednesday, August 9th. BidaskClub lowered shares of Teligent from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Zacks Investment Research lowered shares of Teligent from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th. Finally, ValuEngine lowered shares of Teligent from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $9.33.
Institutional investors have recently bought and sold shares of the business. Teachers Advisors LLC lifted its stake in Teligent by 1.0% in the fourth quarter. Teachers Advisors LLC now owns 65,454 shares of the company’s stock worth $433,000 after purchasing an additional 648 shares during the last quarter. RK Capital Management LLC bought a new stake in Teligent in the second quarter worth $4,581,000. Bank of America Corp DE lifted its stake in Teligent by 9.1% in the first quarter. Bank of America Corp DE now owns 39,458 shares of the company’s stock worth $307,000 after purchasing an additional 3,293 shares during the last quarter. Vanguard Group Inc. lifted its stake in Teligent by 10.4% in the first quarter. Vanguard Group Inc. now owns 1,976,891 shares of the company’s stock worth $15,440,000 after purchasing an additional 185,624 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ bought a new stake in Teligent in the first quarter worth $612,000. 66.00% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: “Teligent, Inc. (TLGT) Expected to Announce Quarterly Sales of $19.17 Million” was reported by BBNS and is owned by of BBNS. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://baseballnewssource.com/markets/teligent-inc-tlgt-expected-to-announce-quarterly-sales-of-19-17-million/1702708.html.
Teligent (NASDAQ:TLGT) traded down 1.27% during midday trading on Friday, reaching $7.01. The company’s stock had a trading volume of 215,458 shares. The company’s market cap is $374.27 million. The stock has a 50-day moving average price of $6.91 and a 200 day moving average price of $6.91. Teligent has a 12 month low of $5.74 and a 12 month high of $9.54.
Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with our FREE daily email newsletter.